Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream

Gaspari, 2003, Immunotherapy of basal cell carcinoma: evolving approaches, Dermatol Surg, 29, 1027 Sullivan, 2003, Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping, Dermatol Surg, 29, 1181 Sterry, 2002, Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low frequency dosing with and without occlusion, Br J Dermatol, 147, 1227, 10.1046/j.1365-2133.2002.05069.x Geisse, 2004, Imiquimod 5% cream for the treatment of superficial basal cell carcinomas: results from two phase III, randomized, vehicle-controlled studies, J Am Acad Dematol, 50, 722, 10.1016/j.jaad.2003.11.066 Schulze, 2005, Imiquimod 5% cream for the treatment os superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe, Br J Dermatol, 152, 939, 10.1111/j.1365-2133.2005.06486.x Shumack, 2002, Efficacy of topical 5% imiquimod for the tyreatment of nodular basal cell carcinoma: comparison of dosing regimes, Arch Dermatol, 138, 1165, 10.1001/archderm.138.9.1165 Schiessl, 2007, Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up, J Drugs Dermatol, 6, 507 Warshauer, 2008, Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy, J Drugs Dermatol, 7, 447 Cowen, 2002, An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream, J Am Acad Dermatol, 47, 240, 10.1067/mjd.2002.126583 Drehs, 2002, Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature, Dermatol Surg, 28, 427 Micali, 2002, Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report, J Dermatol Treatment, 13, 123, 10.1080/09546630260199488 Gollnick, 2005, Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe, Eur J Dermatol, 15, 374 Festa Neto, 2002, Tratamento tópico do carcinoma basocelular superficial e nodular pelo imiquimode creme a 5%: observação de 10 casos, An Bras Dermatol, 77, 693, 10.1590/S0365-05962002000600006 Beutner, 1999, Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream, J Am Acad Dermatol, 1, 1002, 10.1016/S0190-9622(99)70261-6 Marks, 2001, Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose multiple response trial, J Am Acad Dermatol, 44, 807, 10.1067/mjd.2001.113689 Geisse, 2004, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase, randomized, vehicle-controlled studies, J Am Acad Dermatol, 50, 722, 10.1016/j.jaad.2003.11.066